These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Braun-Falco O; Burg G Ther Ggw; 1971 Apr; 110(4):488-500. PubMed ID: 4930022 [No Abstract] [Full Text] [Related]
23. Pityriasis rubra pilaris, type 1. Booth AV; Ma L Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381 [TBL] [Abstract][Full Text] [Related]
24. [Immunosuppressive agents in the treatment of psoriasis]. Ruszczak Z Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862 [No Abstract] [Full Text] [Related]
25. Advances in the treatment of diseases of the skin. Pegum JS Practitioner; 1972 Oct; 209(252):453-9. PubMed ID: 4264252 [No Abstract] [Full Text] [Related]
26. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. Thiers BH J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189 [TBL] [Abstract][Full Text] [Related]
27. [What is new in American dermatology. I]. Hollander AA Hautarzt; 1971 Sep; 22(9):379-83. PubMed ID: 4259528 [No Abstract] [Full Text] [Related]
28. [Therapy of skin- and venereal diseases. Review of the literature 1969]. Walther H Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633 [No Abstract] [Full Text] [Related]
29. [Off-label indications of biological drugs in dermatology]. Cortés B; Laffitte E Rev Med Suisse; 2016 Mar; 12(512):635-8. PubMed ID: 27172693 [TBL] [Abstract][Full Text] [Related]
30. Toxic doses of vitamin A for pityriasis rubra pilaris. Randle HW; Diaz-Perez JL; Winkelmann RK Arch Dermatol; 1980 Aug; 116(8):888-92. PubMed ID: 7406516 [TBL] [Abstract][Full Text] [Related]
31. [Effectiveness and side effects of the treatment of certain dermatoses with methotrexate]. Mashkilleison AL; Glebova LI; Kantsler VS; Kundel' LM; Kliavina VR Vestn Dermatol Venerol; 1973 Oct; 47(10):69-73. PubMed ID: 4782182 [No Abstract] [Full Text] [Related]
32. Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris? Balestri R; Bardazzi F; Antonucci A Br J Dermatol; 2010 Oct; 163(4):896-7; author reply 897-8. PubMed ID: 20662839 [No Abstract] [Full Text] [Related]
33. [Medicamental immunosuppression in dermatology (author's transl)]. Goerz G; Merk H Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720 [TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive drugs in dermatology--benefits and threats. Kowal A; Warmińska J; Krasowska D Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159 [TBL] [Abstract][Full Text] [Related]